Athenex, Inc. Uncategorized Contracts & Agreements

14 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Second Amended and Restated Co-Development Agreement between Baylor College of Medicine and Kuur Therapeutics Limited, dated October 12, 2021
Athenex, Inc.
Biotechnology
2022
Amended and Restated Co-Development Agreement between Baylor College of Medicine and Kuur Therapeutics Limited, dated February 28, 2020
Athenex, Inc.
Biotechnology
2021
Lock-Up Agreement between Athenex, Inc. and each of the parties named therein, dated as of May 4, 2021
Athenex, Inc.
Biotechnology
2021
Lock-Up Agreement between Athenex, Inc. and Touchstone Innovations Businesses LLP (IP Group), dated May 4, 2021
Athenex, Inc.
Biotechnology
2021
Description of Securities
Athenex, Inc.
Biotechnology
2020
Second Amendment to Agreement by and between M+W U.S., Inc. and Athenex, Inc., effective as of October 1, 2018
Athenex, Inc.
Biotechnology
2019
First Amendment to Agreement by and between M+W U.S., Inc. and Athenex, Inc., effective as of March 27, 2018
Athenex, Inc.
Biotechnology
2019
Sublicense Agreement, dated as of December 30, 2018 by and among Chongqing Taihao Pharmaceutical Co. Ltd., Chongqing Jingdong Junzhuo Pharmaceutical Co., Ltd., and Athenex, Inc
Athenex, Inc.
Biotechnology
NY
2019
Letter Agreement by and between Athenex, Inc., Almirall, S.A. and Aqua Pharmaceuticals LLC, dated as of September 26, 2018
Athenex, Inc.
Biotechnology
2018
FIRST AMENDMENT TO THE LETTER AGREEMENT BETWEEN ATHENEX, INC. AND FLINT D. BESECKER DATED DECEMBER 8, 2016
Athenex, Inc.
Biotechnology
2017
- 2 -
Athenex, Inc.
Biotechnology
NY
2017
NANG KUANG PHARMACEUTICAL CO., LTD
Athenex, Inc.
Biotechnology
DE
2017
KINEX PHARMACEUTICALS LLC FIRST AMENDED AND RESTATED 2007 COMMON UNIT OPTION PLAN (AS OF OCTOBER 1, 2012)
Athenex, Inc.
Biotechnology
DE
2017
KINEX PHARMACEUTICALS LLC FIRST AMENDED AND RESTATED 2004 COMMON UNIT OPTION PLAN (AS OF OCTOBER 1, 2012)
Athenex, Inc.
Biotechnology
DE
2017